🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
14.80
-0.09 (-0.60%)
Nov 20, 2026, 12:03 PM EST - Market open

Aurinia Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
45.7980.1683.448.7694.09231.64
Short-Term Investments
440.74317.78275.04301.61295.22234.18
Cash & Short-Term Investments
486.53397.94358.44350.37389.31465.82
Cash Growth
38.41%11.02%2.30%-10.00%-16.43%16.94%
Accounts Receivable
47.4141.4536.5424.0913.4815.41
Other Receivables
1.20.70.60.71.1-
Receivables
48.6142.1537.1424.7914.5815.41
Inventory
43.7345.6939.2339.7124.7519.33
Prepaid Expenses
5.925.7511.229.4913.5811.71
Restricted Cash
0.350.050.040.120.080.26
Other Current Assets
2.750.380.530.330.230.8
Total Current Assets
587.89491.97446.6424.8442.54513.32
Property, Plant & Equipment
63.979.5798.87116.578.569.8
Long-Term Investments
---0.2--
Other Intangible Assets
3.173.764.364.986.438.4
Long-Term Deferred Tax Assets
170.65176.19----
Other Long-Term Assets
0.090.090.821.5213.3411.84
Total Assets
825.7751.59550.65548.06470.86543.37

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.013.315.194.333.093.88
Accrued Expenses
63.366.4754.1250.0636.2830.25
Current Portion of Leases
17.9617.5915.0715.60.941.06
Current Income Taxes Payable
----0.630.81
Current Unearned Revenue
10.413.72114.813.150.19
Other Current Liabilities
1.322.6312.392.392.034.45
Total Current Liabilities
96.0193.7297.7677.1946.1140.65
Long-Term Leases
40.7157.2264.382.017.157.68
Long-Term Unearned Revenue
7.1612.651.7---
Other Long-Term Liabilities
1.196.669.4110.9112.1715.95
Total Liabilities
168.19170.26173.17170.1165.4364.28

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,1281,1201,1881,2001,1851,177
Additional Paid-In Capital
77.04111.26127120.7985.4959.01
Retained Earnings
-545.9-649.37-936.57-942.32-864.3-756.12
Comprehensive Income & Other
-1.13-0.6-0.65-0.73-1.06-0.85
Shareholders' Equity
657.52581.33377.48377.95405.44479.09
Total Liabilities & Equity
825.7751.59550.65548.06470.86543.37

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
58.6674.8179.3797.618.098.74
Net Cash (Debt)
427.86323.13279.07252.76381.22457.08
Net Cash Growth
56.56%15.79%10.41%-33.70%-16.60%17.22%
Net Cash Per Share
3.152.331.911.762.693.53
Filing Date Shares Outstanding
134132.97137.34144.62142.58141.65
Total Common Shares Outstanding
134132.32140.88143.83142.27141.6
Working Capital
491.88398.24348.83347.61396.43472.68
Book Value Per Share
4.914.392.682.632.853.38
Tangible Book Value
654.35577.57373.12372.98399.01470.69
Tangible Book Value Per Share
4.884.362.652.592.803.32
Machinery
2.022.022.022.021.871.88
Construction In Progress
----0.260.39
Leasehold Improvements
3.243.243.243.242.982.98
SEC Filings: 10-K · 10-Q